Saad Z. Usmani, MD, MBA, FACP, FASCO, discussed quadruplet induction, extended maintenance, and when a community clinician should call a myeloma center.
|Articles|August 1, 1998
Oncology NEWS International
- Oncology NEWS International Vol 7 No 8
- Volume 7
- Issue 8
Cancer Care Adds Ovarian Cancer Section to Website
NEW YORK--Cancer Care, Inc. has launched a new online resource for ovarian cancer patients and their families and friends. A new section added to Cancer Care’s website (www.cancercare.org) offers a comprehensive overview of ovarian cancer and a resource guide.
Advertisement
NEW YORK--Cancer Care, Inc. has launched a new online resource for ovarian cancer patients and their families and friends. A new section added to Cancer Cares website (
The new addition to the website is made possible through an educational grant from SmithKline Beecham Oncology. The ovarian cancer section complements Cancer Cares other website sections on specific types of cancer such as breast, prostate, lung, colon, brain, and melanoma.
Information provided about the disease includes tumor differentiation and staging, risk factors, coping, and diagnostic and treatment options. Answers to common questions about ovarian cancer are also included.
"We wanted ovarian cancer patients to be able to address any technical or practical concerns they have regarding the disease," said Diane Blum, MSW, executive director of Cancer Care. "This website section, as with all of Cancer Cares website sections, encourages patients to utilize all available resources for their medical, emotional, and financial needs. We believe it will help connect patients with essential resources."
Articles in this issue
over 28 years ago
Taxol, Gemzar, Other Therapies Studied in Metastatic Bladder Cancerover 28 years ago
Medicare+Choice Opens Certificationover 28 years ago
Consumer Advocates Win a Voice in NCI Programsover 28 years ago
Paclitaxel Shows Antiangiogenesis Effects in Mouse Modelover 28 years ago
Henney Nominated for FDA Commissionerover 28 years ago
FDA Approves ImageChecker Computer Systemover 28 years ago
Pittsburgh Seeks Breast Cancer Patients for Study on Copingover 28 years ago
Octreotide Imaging Improves Staging of Hodgkin’s Diseaseover 28 years ago
Tobacco Contributions Are Linked to Votes Against Tobacco BillAdvertisement
Related to this article
Saad Z. Usmani, MD, MBA, FACP, FASCO, discussed the threshold he will act on in standard-risk disease, and the trial that would make the decision firmer.
Daniel Y.C. Heng, MD, MPH, FRCPC, explained how he manages anemia, hypoxia, and cardiac toxicity with belzutifan plus lenvatinib for renal cell carcinoma.
National registry data show 5-year overall survival in children and adolescents with cancer rose from 60% in 1975 to 90% in 2017.
Model data suggest anthracycline-based chemotherapy may cost breast cancer survivors a median of 9.4 life-years through biological age acceleration.
Daniel Y.C. Heng, MD, MPH, FRCPC, discussed final LITESPARK-011 data, toxicity management, and treatment sequencing in advanced renal cell carcinoma.
In a retrospective analysis, teclistamab produced response rates numerically higher than in MajesTEC-1, with missed doses not compromising outcomes.
NCCN guidelines now list the ArteraAI Prostate Test for risk stratification in patients with biochemical recurrence after radical prostatectomy.
Advertisement
Advertisement
Trending on CancerNetwork
1
Anthracycline Chemo May Accelerate Biological Aging in Breast Cancer Survivors
2
CELMoDs With CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
3
Survival in Childhood and Adolescent Cancers Improves, but Racial Disparities Persist
4
ASCENT-03: Sacituzumab Govitecan Versus Chemotherapy in First-Line Metastatic TNBC
5